Pfizer’s Prevenar 13 Scores Against Adult Pneumonia
Big pharma Pfizer (PFE) said Monday that its vaccine Prevenar 13 prevented pneumonia in a giant study of elderly subjects, potentially greatly expanding sales of the product. Pfizer was studying a particular variety called community-acquired pneumoccal pneumonia (CAP), which the press release called “a significant cause of illness and death in adults around the world.” Some 85,000 subjects participated, in a double-blind, placebo-controlled,